Publication | Open Access
Efficacy of Endocrine Therapy Plus Trastuzumab and Pertuzumab vs De-escalated Chemotherapy in Patients with Hormone Receptor–Positive/<i>ERBB2</i>-Positive Early Breast Cancer
30
Citations
26
References
2023
Year
ClinicalTrials.gov Identifier: NCT03272477.
| Year | Citations | |
|---|---|---|
Page 1
Page 1